Medinice (WAR:ICE) Beneish M-Score: 0.00 (As of Jun. 26, 2026)


WAR:ICE Medinice SA WAR:ICE
24 GF Score
Price zł69.00
GF Value zł0.99
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medinice Beneish M-Score?

Medinice WAR:ICE -3.63% 24 Beneish M-Score is 0.00 as of Jun. 26, 2026. GuruFocus rates WAR:ICE with a GF Score™ of 24/100 and a GF Value™ of zł0.99 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 766 Medical Devices & Instruments companies, Medinice ranks worse than 130548.17% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Medinice's Beneish M-Score or its related term are showing as below:

During the past 10 years, the highest Beneish M-Score of Medinice was 322.71. The lowest was -5.19. And the median was -2.35.


Medinice Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Medinice's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medinice Beneish M-Score Chart

Medinice Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.53 -2.95 -3.02 -2.11 0.00

Medinice Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

WAR:ICE vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, Medinice's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medinice Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medinice's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Medinice's Beneish M-Score falls into.


WAR:ICE
24GF Score
Medinice SA WAR:ICE
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medinice Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Medinice for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * +0.528 * +0.404 * +0.892 * +0.115 *
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * +4.679 * -0.327 *
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was zł0.01 Mil.
Revenue was zł0.00 Mil.
Gross Profit was zł-0.17 Mil.
Total Current Assets was zł9.95 Mil.
Total Assets was zł92.73 Mil.
Property, Plant and Equipment(Net PPE) was zł0.59 Mil.
Depreciation, Depletion and Amortization(DDA) was zł0.24 Mil.
Selling, General, & Admin. Expense(SGA) was zł0.00 Mil.
Total Current Liabilities was zł1.45 Mil.
Long-Term Debt & Capital Lease Obligation was zł0.18 Mil.
Net Income was zł-6.72 Mil.
Gross Profit was zł0.00 Mil.
Cash Flow from Operations was zł-5.58 Mil.
Total Receivables was zł0.05 Mil.
Revenue was zł0.19 Mil.
Gross Profit was zł-0.03 Mil.
Total Current Assets was zł9.85 Mil.
Total Assets was zł86.60 Mil.
Property, Plant and Equipment(Net PPE) was zł0.64 Mil.
Depreciation, Depletion and Amortization(DDA) was zł0.31 Mil.
Selling, General, & Admin. Expense(SGA) was zł0.00 Mil.
Total Current Liabilities was zł2.46 Mil.
Long-Term Debt & Capital Lease Obligation was zł0.17 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.006 / 0) / (0.048 / 0.188)
= / 0.255319
=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(-0.026 / 0.188) / (-0.166 / 0)
=-0.138298 /
=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (9.951 + 0.593) / 92.732) / (1 - (9.846 + 0.638) / 86.604)
=0.886296 / 0.878943
=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0 / 0.188
=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.305 / (0.305 + 0.638)) / (0.242 / (0.242 + 0.593))
=0.323436 / 0.28982
=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 0) / (0 / 0.188)
= / 0
=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.178 + 1.448) / 92.732) / ((0.171 + 2.464) / 86.604)
=0.017534 / 0.030426
=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-6.723 - 0 - -5.583) / 92.732
=-0.012293

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 0.00 mean?
Medinice (WAR:ICE) has a Beneish M-Score of 0.00 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medinice and its competitors. According to the industry distribution chart, Medinice ranks #999999 out of 766 companies in the Medical Devices & Instruments industry.
Is Medinice's Beneish M-Score too high?
Medinice's current Beneish M-Score is 0.00. Based on the distribution chart, Medinice ranks #999999 out of 766 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medinice has a GF Score™ of 24/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medinice's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medinice ranks #999999 out of 766 companies for Beneish M-Score. This places Medinice in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medinice and its competitors. Medinice's current Beneish M-Score is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinice stock overvalued right now?
Based on GuruFocus' analysis, Medinice (WAR:ICE) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.99, compared to a current price of zł69.00 — trading 6869.7% above its estimated fair value. The current Beneish M-Score is 0.00. Medinice's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Medinice (WAR:ICE), the current Beneish M-Score is 0.00 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medinice (WAR:ICE) Overvalued in 2026?

Based on GuruFocus' analysis, Medinice stock appears to be overvalued. The current stock price of zł69.00 is trading 6869.7% above its estimated GF Value™ of zł0.99. GuruFocus considers Medinice to be Significantly Overvalued.

Key valuation signals for WAR:ICE:

  • Beneish M-Score: 0.00
  • GF Value™: zł0.99 vs. price of zł69.00 (6869.7% above fair value)
  • GF Score™: 24/100 with 2 warning signs

No single metric tells the full story. See the WAR:ICE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medinice Business Description

Other Exchanges 77E:Germany
Address Hankiewicza Street 2, Warszawa, POL, 02-103
Medinice SA is a Polish company operating in the MedTech industry. The company is engaged in creating, developing and commercializing solutions in the field of medicine, in particular, cardiology and cardio surgery. Its portfolio includes close around 12 projects including CathAIO, an electrode with universal diagnostic, electrophysiological, haemodinamic and biohemic functions and can be used for RF ablation; cryoapplicator, for minimally invasive cardiosurgical cryoablation; Med-iConsole allows to reduce the need to use multiple computer devices during electrophysiological treatment; Minimax and Pacepress.
24GF Score

Get the complete analysis for WAR:ICE

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł69.00
Price
zł0.99
GF Value